DV Medical Supply, Inc.

2000 W 135th Street
Gardena, CA. 90249
US

800-438-2568

Cefdinir for Oral Suspension 250mg/5mL 60mL

In Stock.
Part Number:DVM-107354A
MPN:
Manufacturer: Teva Pharmaceuticals USA Inc

NDC:

00093-4137-64
You need to have an approved DV Med account to order this product.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefdinir for oral suspension USP and other antibacterial drugs, cefdinir for oral suspension USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Cefdinir for oral suspension USP is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.

Adults and Adolescents
Community-Acquired Pneumonia
Caused by Haemophilus influenzae (including ß-lactamase producing strains), Haemophilus parainfluenzae (including ß-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including ß-lactamase producing strains) (see CLINICAL STUDIES).

Acute Exacerbations of Chronic Bronchitis
Caused by Haemophilus influenzae (including ß-lactamase producing strains), Haemophilus parainfluenzae (including ß-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including ß-lactamase producing strains).

Acute Maxillary Sinusitis
Caused by Haemophilus influenzae (including ß-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including ß-lactamase producing strains).

NOTE: For information on use in pediatric patients, see Pediatric Use and DOSAGE AND ADMINISTRATION.

Pharyngitis/Tonsillitis
Caused by Streptococcus pyogenes (see CLINICAL STUDIES).

NOTE: Cefdinir is effective in the eradication of S. pyogenes from the oropharynx. Cefdinir has not, however, been studied for the prevention of rheumatic fever following S. pyogenes pharyngitis/tonsillitis. Only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever.

Uncomplicated Skin and Skin Structure Infections
Caused by Staphylococcus aureus (including ß-lactamase producing strains) and Streptococcus pyogenes.

Pediatric Patients
Acute Bacterial Otitis Media caused by Haemophilus influenzae (including ß-lactamase producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), and Moraxella catarrhalis (including ß-lactamase producing strains).

Pharyngitis/Tonsillitis
Caused by Streptococcus pyogenes (see CLINICAL STUDIES).

NOTE: Cefdinir is effective in the eradication of S. pyogenes from the oropharynx. Cefdinir has not, however, been studied for the prevention of rheumatic fever following S. pyogenes pharyngitis/tonsillitis. Only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever.

Uncomplicated Skin and Skin Structure Infections
Caused by Staphylococcus aureus (including ß-lactamase producing strains) and Streptococcus pyogenes.